Encore Research Group-Jacksonville Center for Clinical Resea — Jacksonville, Florida

Encore Research Group-Jacksonville Center for Clinical Resea is a clinical research site located in Jacksonville, Florida, United States 32216.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Encore Research Group-Jacksonville Center for Clinical Resea has participated in 2 clinical trials.

Therapeutic areas: Psoriasis, Seasonal Influenza.

Sponsors: Amgen, ModernaTX, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jacksonville

Browse all research sites in Florida · View every site in Jacksonville

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Encore Research Group-Jacksonville Center for Clinical Resea?

Encore Research Group-Jacksonville Center for Clinical Resea has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Encore Research Group-Jacksonville Center for Clinical Resea conducted?

Encore Research Group-Jacksonville Center for Clinical Resea has 2 clinical trials on record. Their work covers Psoriasis, Seasonal Influenza.

Is Encore Research Group-Jacksonville Center for Clinical Resea accredited by Crixeo Clinical Trials?

Encore Research Group-Jacksonville Center for Clinical Resea has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Encore Research Group-Jacksonville Center for Clinical Resea?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.